AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 20110026 — intervention group
Group type: EXPERIMENTAL
Intervention: Barnidipine (10-20 mg once daily)
Number of subjects: 21
Study 20110026 — intervention group
Group type: COMPARATOR
Intervention: Control group (normotensive subjects)
Number of subjects: 21
Study 17275927 — intervention group
Group type: EXPERIMENTAL
Intervention: Unilateral cochlear implant turned on
Number of subjects: 36
Study 17275927 — intervention group
Group type: EXPERIMENTAL
Intervention: Unilateral cochlear implant turned off
Number of subjects: 36
Study 17275927 — intervention group
Group type: COMPARATOR
Intervention: Standing on foam with closed eyes (Condition 2)
Number of subjects: 36
Study 15533270 — intervention group
Group type: EXPERIMENTAL
Intervention: Substitution of high‐fat foods with reduced‐fat products
Number of subjects: 80
Study 15533270 — intervention group
Group type: EXPERIMENTAL
Intervention: Reduction of high‐fat foods
Number of subjects: 80
Study 15533270 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of substitution and reduction strategies
Number of subjects: 80
Study 15533270 — intervention group
Group type: COMPARATOR
Intervention: No advice given
Number of subjects: 80
Study 11322357 — intervention group
Group type: EXPERIMENTAL
Intervention: Thyroxine therapy for subclinical hypothyroidism with TSH > 10 mIU/L
Number of subjects: 0
Study 11322357 — intervention group
Group type: EXPERIMENTAL
Intervention: Individualized decision for therapy for subclinical hypothyroidism with TSH between 5 and 10 mIU/L
Number of subjects: 0
Study 11322357 — intervention group
Group type: EXPERIMENTAL
Intervention: Treatment for subclinical hyperthyroidism
Number of subjects: 0
Study 9491823 — intervention group
Group type: EXPERIMENTAL
Intervention: CP-105,696 (5 to 640 mg single oral dose)
Number of subjects: 48
Study 7819683 — intervention group
Group type: EXPERIMENTAL
Intervention: Airway opening sensors
Number of subjects: 36
Study 7819683 — intervention group
Group type: EXPERIMENTAL
Intervention: Inspiratory pressure transducers
Number of subjects: 36
Study 7819683 — intervention group
Group type: EXPERIMENTAL
Intervention: Expiratory pressure transducers
Number of subjects: 36
Study 7819683 — intervention group
Group type: EXPERIMENTAL
Intervention: Graseby capsule
Number of subjects: 36
Study 7819683 — intervention group
Group type: EXPERIMENTAL
Intervention: Strain gauges
Number of subjects: 36
Study 7819683 — intervention group
Group type: EXPERIMENTAL
Intervention: Oesophageal pressure
Number of subjects: 36
Study 7819683 — intervention group
Group type: COMPARATOR
Intervention: Conventional apnoea monitor
Number of subjects: 36
Study 7819683 — intervention group
Group type: EXPERIMENTAL
Intervention: Total delay for airway sensors in severe lung disease
Number of subjects: 36
Study 7819683 — intervention group
Group type: EXPERIMENTAL
Intervention: Total delay for airway sensors in near normal infants
Number of subjects: 36
Study 2512163 — intervention group
Group type: EXPERIMENTAL
Intervention: Antibiotics (mainly ampicillin and netilmicin)
Number of subjects: 36
Study 2512163 — intervention group
Group type: COMPARATOR
Intervention: Adapted cow's milk formula with lard
Number of subjects: 36
Study 1180124 — intervention group
Group type: EXPERIMENTAL
Intervention: Phenobarbital 100 mg daily for 7 days
Number of subjects: 24
Study 1180124 — intervention group
Group type: EXPERIMENTAL
Intervention: Diazepam 15 mg daily for 7 days
Number of subjects: 24
Study 1180124 — intervention group
Group type: EXPERIMENTAL
Intervention: Oxazepam 75 mg daily for 7 days
Number of subjects: 24
Study 1180124 — intervention group
Group type: COMPARATOR
Intervention: Baseline values
Number of subjects: 24
Study 31769500 — intervention group
Group type: EXPERIMENTAL
Intervention: ThinPrep automated method (TPAM)
Number of subjects: 1500
Study 31769500 — intervention group
Group type: COMPARATOR
Intervention: ThinPrep manual method (TPMM)
Number of subjects: 1500
Study 31320177 — intervention group
Group type: EXPERIMENTAL
Intervention: Rituximab (RTX)
Number of subjects: 78
Study 31320177 — intervention group
Group type: COMPARATOR
Intervention: Cyclophosphamide (CYC)/azathioprine (AZA)
Number of subjects: 78
Study 31320177 — intervention group
Group type: COMPARATOR
Intervention: Not applicable
Number of subjects: 78
Study 29515726 — intervention group
Group type: EXPERIMENTAL
Intervention: 5 mg hypobaric bupivacaine
Number of subjects: 108
Study 29515726 — intervention group
Group type: COMPARATOR
Intervention: 7.5 mg hypobaric bupivacaine
Number of subjects: 108
Study 26287302 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexmedetomidine (1 μg/kg)
Number of subjects: 60
Study 26287302 — intervention group
Group type: COMPARATOR
Intervention: Placebo (normal saline)
Number of subjects: 60
Study 23453104 — intervention group
Group type: EXPERIMENTAL
Intervention: Primary percutaneous coronary intervention (PCI)
Number of subjects: 5745
Study 23453104 — intervention group
Group type: COMPARATOR
Intervention: Baseline risk factors
Number of subjects: 5745
Study 23453104 — intervention group
Group type: EXPERIMENTAL
Intervention: Dynamic risk models
Number of subjects: 5745
Study 16143706 — intervention group
Group type: EXPERIMENTAL
Intervention: Aspirin plus warfarin (A+W)
Number of subjects: 25307
Study 16143706 — intervention group
Group type: EXPERIMENTAL
Intervention: Aspirin plus warfarin (A+W) with INR of 2-3
Number of subjects: 25307
Study 15058044 — intervention group
Group type: EXPERIMENTAL
Intervention: Incremental cycling exercise test after blood donation (450 ml)
Number of subjects: 13
Study 15058044 — intervention group
Group type: COMPARATOR
Intervention: Control study (before blood donation)
Number of subjects: 13
Study 15058044 — intervention group
Group type: COMPARATOR
Intervention: Control study
Number of subjects: 13
Study 10355400 — intervention group
Group type: EXPERIMENTAL
Intervention: Glyceryl trinitrate
Number of subjects: 50
Study 10355400 — intervention group
Group type: EXPERIMENTAL
Intervention: Papaverine
Number of subjects: 50
Study 10355400 — intervention group
Group type: EXPERIMENTAL
Intervention: Nicardipine
Number of subjects: 50
Study 10355400 — intervention group
Group type: EXPERIMENTAL
Intervention: Linsidomine
Number of subjects: 50
Study 10355400 — intervention group
Group type: COMPARATOR
Intervention: Normal saline solution
Number of subjects: 50
Study 8686260 — intervention group
Group type: EXPERIMENTAL
Intervention: French measles vaccine
Number of subjects: 181
Study 8686260 — intervention group
Group type: EXPERIMENTAL
Intervention: Japanese measles vaccine
Number of subjects: 181
Study 8686260 — intervention group
Group type: EXPERIMENTAL
Intervention: Russian measles vaccine
Number of subjects: 181
Study 1822966 — intervention group
Group type: EXPERIMENTAL
Intervention: Very high purity concentrate
Number of subjects: 20
Study 1822966 — intervention group
Group type: COMPARATOR
Intervention: Intermediate purity concentrate
Number of subjects: 20
Study 7150898 — intervention group
Group type: EXPERIMENTAL
Intervention: 3F/week radiotherapy
Number of subjects: 706
Study 7150898 — intervention group
Group type: COMPARATOR
Intervention: 5F/week radiotherapy
Number of subjects: 706
Study 7150898 — intervention group
Group type: EXPERIMENTAL
Intervention: Sub-groups with highly localized tumours
Number of subjects: 706
Study 31060605 — intervention group
Group type: EXPERIMENTAL
Intervention: Appropriate management of malaria cases in Zambézia (52%, 95% CI 42-62)
Number of subjects: 1840
Study 31060605 — intervention group
Group type: EXPERIMENTAL
Intervention: Appropriate management of malaria cases in Cabo Delgado (49%, 95% CI 42-57)
Number of subjects: 1840
Study 31060605 — intervention group
Group type: EXPERIMENTAL
Intervention: Appropriate management of malaria cases in Maputo Province (14%, 5-34)
Number of subjects: 1840
Study 31060605 — intervention group
Group type: EXPERIMENTAL
Intervention: Testing of febrile patients in Maputo Province (46%)
Number of subjects: 1840
Study 31060605 — intervention group
Group type: EXPERIMENTAL
Intervention: Anti-malarial treatment of patients with negative malaria test in Maputo Province (8%, 2-23)
Number of subjects: 1840
Study 31060605 — intervention group
Group type: EXPERIMENTAL
Intervention: Anti-malarial treatment of patients with negative malaria test in Zambézia (22%, 14-32)
Number of subjects: 1840
Study 31060605 — intervention group
Group type: EXPERIMENTAL
Intervention: Correct recitation of dosing instructions for anti-malarial treatment (58-62%)
Number of subjects: 1840
Study 28264130 — intervention group
Group type: EXPERIMENTAL
Intervention: RGTA eye drops
Number of subjects: 60
Study 28264130 — intervention group
Group type: COMPARATOR
Intervention: Control group (identical medical agents postoperatively)
Number of subjects: 60
Study 26621819 — intervention group
Group type: EXPERIMENTAL
Intervention: Ranitidine 300 mg plus omeprazole 40 mg
Number of subjects: 21
Study 26621819 — intervention group
Group type: COMPARATOR
Intervention: Omeprazole 40 mg
Number of subjects: 21
Study 26621819 — intervention group
Group type: COMPARATOR
Intervention: Ranitidine 300 mg
Number of subjects: 21
Study 24321717 — intervention group
Group type: EXPERIMENTAL
Intervention: Metformin
Number of subjects: 10
Study 24321717 — intervention group
Group type: COMPARATOR
Intervention: Aerobic exercise
Number of subjects: 10
Study 21519556 — intervention group
Group type: EXPERIMENTAL
Intervention: Composite alloplast with open flap debridement
Number of subjects: 10
Study 21519556 — intervention group
Group type: COMPARATOR
Intervention: Open flap debridement alone (Control)
Number of subjects: 10
Study 18285439 — intervention group
Group type: COMPARATOR
Intervention: Experimental treatments
Number of subjects: 20
Study 18285439 — intervention group
Group type: COMPARATOR
Intervention: Standard treatments
Number of subjects: 20
Study 16702841 — intervention group
Group type: EXPERIMENTAL
Intervention: Botulinum toxin A
Number of subjects: 0
Study 16702841 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 14530751 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-help rehabilitation manual plus ward visits, three telephone calls at home, and clinic appointments at 8 wks and 6 months.
Number of subjects: 126
Study 14530751 — intervention group
Group type: COMPARATOR
Intervention: Control group received ward visits, three telephone calls at home, and clinic appointments at 8 wks and 6 months.
Number of subjects: 126
Study 10871146 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous wattage ultrasound (CWUS) at 3 MHz, 1.25 W/cm2 combined with stretching
Number of subjects: 21
Study 10871146 — intervention group
Group type: COMPARATOR
Intervention: Sham continuous wattage ultrasound combined with stretching
Number of subjects: 21
Study 9029265 — intervention group
Group type: EXPERIMENTAL
Intervention: Crude tissue section lysates
Number of subjects: 0
Study 9029265 — intervention group
Group type: COMPARATOR
Intervention: Purified DNA samples
Number of subjects: 0
Study 1508060 — intervention group
Group type: EXPERIMENTAL
Intervention: SHD 386L
Number of subjects: 45
Study 1508060 — intervention group
Group type: COMPARATOR
Intervention: Levonorgestrel alone (Control)
Number of subjects: 45
Study 6652480 — intervention group
Group type: EXPERIMENTAL
Intervention: Directional advance information (DAI) about the voluntary movement that had to be performed, specifically precuing an extension movement.
Number of subjects: 9
Study 6652480 — intervention group
Group type: EXPERIMENTAL
Intervention: Warning signal precuing a flexion movement.
Number of subjects: 9
Study 6652480 — intervention group
Group type: EXPERIMENTAL
Intervention: Warning signal precuing an extension movement.
Number of subjects: 9
Study 6652480 — intervention group
Group type: EXPERIMENTAL
Intervention: Fast-performing subjects compared to slow-performing subjects.
Number of subjects: 9
Study 6652480 — intervention group
Group type: EXPERIMENTAL
Intervention: EMG activity recorded between 20 and 80 ms after the stretch started.
Number of subjects: 9
Study 6652480 — intervention group
Group type: EXPERIMENTAL
Intervention: Time course of M3 response to stretch.
Number of subjects: 9
Study 30272584 — intervention group
Group type: EXPERIMENTAL
Intervention: Gaviscon Double Action (Gaviscon DA)
Number of subjects: 424
Study 30272584 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 424
Study 30557377 — intervention group
Group type: EXPERIMENTAL
Intervention: Neuromuscular blockade (NMB) infusion for 24 hours
Number of subjects: 81
Study 30557377 — intervention group
Group type: COMPARATOR
Intervention: Placebo infusion for 24 hours
Number of subjects: 81
Study 30557377 — intervention group
Group type: EXPERIMENTAL
Intervention: NMB infusion
Number of subjects: 81
Study 30557377 — intervention group
Group type: COMPARATOR
Intervention: Placebo infusion
Number of subjects: 81
Study 27803393 — intervention group
Group type: EXPERIMENTAL
Intervention: Elevated serum levels of hsCRP
Number of subjects: 1065
Study 27803393 — intervention group
Group type: EXPERIMENTAL
Intervention: Carotid narrowing over 50% and hsCRP levels >0.29 mg/dL
Number of subjects: 1065
Study 27803393 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined assessment of carotid stenosis and hsCRP
Number of subjects: 1065
Study 24671507 — intervention group
Group type: EXPERIMENTAL
Intervention: Vandetanib 300 mg oral daily plus bicalutamide 50 mg oral daily (Arm A)
Number of subjects: 39
Study 24671507 — intervention group
Group type: COMPARATOR
Intervention: Bicalutamide 50 mg oral daily alone (Arm B)
Number of subjects: 39
Study 22364395 — intervention group
Group type: EXPERIMENTAL
Intervention: Dynamic auditory information about the object's trajectory
Number of subjects: 72
Study 22364395 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous sound with no information about the object's location
Number of subjects: 72
Study 22364395 — intervention group
Group type: EXPERIMENTAL
Intervention: Discontinuous auditory information or auditory information dislocated relative to vision
Number of subjects: 72
Study 20855048 — intervention group
Group type: EXPERIMENTAL
Intervention: Prolonged Exposure Therapy for Adolescents (PE‐A)
Number of subjects: 38
Study 20855048 — intervention group
Group type: COMPARATOR
Intervention: Time-Limited Dynamic Therapy for Adolescents (TLDP‐A)
Number of subjects: 38
Study 17661955 — intervention group
Group type: EXPERIMENTAL
Intervention: Desipramine 100 mg/d
Number of subjects: 0
Study 17661955 — intervention group
Group type: EXPERIMENTAL
Intervention: Gabapentin 1,800 mg/d
Number of subjects: 0
Study 17661955 — intervention group
Group type: EXPERIMENTAL
Intervention: Pregabalin 450 mg/d
Number of subjects: 0
Study 16305870 — intervention group
Group type: EXPERIMENTAL
Intervention: Pulmonary autografts
Number of subjects: 40
Study 16305870 — intervention group
Group type: COMPARATOR
Intervention: Mechanical valve (Edwards MIRA)
Number of subjects: 40
Study 12413112 — intervention group
Group type: EXPERIMENTAL
Intervention: 24% oxygen supply (experimental group)
Number of subjects: 201
Study 12413112 — intervention group
Group type: COMPARATOR
Intervention: 100% oxygen supply (control group)
Number of subjects: 201
Study 10214833 — intervention group
Group type: EXPERIMENTAL
Intervention: Raloxifene (60 mg/d)
Number of subjects: 8
Study 10214833 — intervention group
Group type: COMPARATOR
Intervention: HRT
Number of subjects: 8
Study 10214833 — intervention group
Group type: COMPARATOR
Intervention: Estrogen
Number of subjects: 8
Study 7601950 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.05% desonide ointment
Number of subjects: 113
Study 7601950 — intervention group
Group type: COMPARATOR
Intervention: 1% hydrocortisone ointment
Number of subjects: 113
Study 2082488 — intervention group
Group type: EXPERIMENTAL
Intervention: Aspirin-dipyridamole combination
Number of subjects: 376
Study 2082488 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 376
Study 582746 — intervention group
Group type: EXPERIMENTAL
Intervention: 3 X 1 mg difenoxin hydrochloride (Lyspafen)
Number of subjects: 10
Study 582746 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study 31084684 — intervention group
Group type: EXPERIMENTAL
Intervention: Mobile Air‐Smart Spirometer
Number of subjects: 200
Study 31084684 — intervention group
Group type: COMPARATOR
Intervention: Desktop Spirometer
Number of subjects: 200
Study 28288407 — intervention group
Group type: EXPERIMENTAL
Intervention: Problem-solving therapy
Number of subjects: 220
Study 28288407 — intervention group
Group type: COMPARATOR
Intervention: Supportive therapy
Number of subjects: 220
Study 24297636 — intervention group
Group type: EXPERIMENTAL
Intervention: LigaSure vessel-sealing system
Number of subjects: 40
Study 24297636 — intervention group
Group type: COMPARATOR
Intervention: Traditional technique (Control)
Number of subjects: 40
Study 23927461 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined hydroxyurea (HU) and recombinant human erythropoietin (rHuEPO)
Number of subjects: 80
Study 23927461 — intervention group
Group type: COMPARATOR
Intervention: Single hydroxyurea (HU) therapy
Number of subjects: 80
Study 21830417 — intervention group
Group type: EXPERIMENTAL
Intervention: PlasmaJet (5mL)
Number of subjects: 58
Study 21830417 — intervention group
Group type: COMPARATOR
Intervention: Fibrin glue (Tissucol)
Number of subjects: 58
Study 19858327 — intervention group
Group type: EXPERIMENTAL
Intervention: Resistance exercise with mirrors
Number of subjects: 32
Study 19858327 — intervention group
Group type: COMPARATOR
Intervention: Resistance exercise without mirrors
Number of subjects: 32
Study 16429701 — intervention group
Group type: EXPERIMENTAL
Intervention: Tyrian SPE
Number of subjects: 30
Study 16429701 — intervention group
Group type: COMPARATOR
Intervention: Prime & Bond NT
Number of subjects: 30
Study 16429701 — intervention group
Group type: EXPERIMENTAL
Intervention: AdheSE
Number of subjects: 30
Study 16429701 — intervention group
Group type: EXPERIMENTAL
Intervention: Clearfil SE Bond
Number of subjects: 30
Study 16429701 — intervention group
Group type: EXPERIMENTAL
Intervention: AdheSE and Clearfil SE Bond
Number of subjects: 30
Study 15613919 — intervention group
Group type: EXPERIMENTAL
Intervention: Raloxifene 60 mg
Number of subjects: 113
Study 15613919 — intervention group
Group type: EXPERIMENTAL
Intervention: Raloxifene 150 mg
Number of subjects: 113
Study 15613919 — intervention group
Group type: COMPARATOR
Intervention: Conjugated equine estrogen/medroxyprogesterone acetate
Number of subjects: 113
Study 15613919 — intervention group
Group type: EXPERIMENTAL
Intervention: Raloxifene 120 mg
Number of subjects: 113
Study 15613919 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 113
Study 15613919 — intervention group
Group type: EXPERIMENTAL
Intervention: Raloxifene
Number of subjects: 113
Study 11320043 — intervention group
Group type: EXPERIMENTAL
Intervention: rhG‐CSF (10 microg/kg/day) administered intravenously
Number of subjects: 28
Study 11320043 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 28
Study 9300214 — intervention group
Group type: EXPERIMENTAL
Intervention: Peer presence and personal factors (4 personal factors assessed)
Number of subjects: 0
Study 9300214 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-regulation model (SRM) variables (ability beliefs, preference for thrill seeking, peer nomination, competitiveness, interest)
Number of subjects: 0
Study 8396091 — intervention group
Group type: EXPERIMENTAL
Intervention: Single oral-dose of 1 g azithromycin
Number of subjects: 120
Study 8396091 — intervention group
Group type: COMPARATOR
Intervention: Seven-day course of 100 mg doxycycline twice-daily
Number of subjects: 120
Study 3098194 — intervention group
Group type: EXPERIMENTAL
Intervention: sodium aurothiomalate
Number of subjects: 90
Study 3098194 — intervention group
Group type: EXPERIMENTAL
Intervention: auranofin
Number of subjects: 90
Study 3098194 — intervention group
Group type: COMPARATOR
Intervention: auranofin placebo
Number of subjects: 90
Study 29324708 — intervention group
Group type: EXPERIMENTAL
Intervention: Signal processing procedure using Golay complementary waveforms with Binomial Design algorithm and one of three proposed waveform transmission ordering algorithms
Number of subjects: 0
Study 29324708 — intervention group
Group type: COMPARATOR
Intervention: Binomial Design algorithm
Number of subjects: 0
Study 27355509 — intervention group
Group type: EXPERIMENTAL
Intervention: Point-of-Care (POC) diagnostic technology using Alere q platform for HIV DNA PCR testing
Number of subjects: 2867
Study 27355509 — intervention group
Group type: COMPARATOR
Intervention: Standard care (control group not explicitly mentioned but implied)
Number of subjects: 2867
Study 24405797 — intervention group
Group type: EXPERIMENTAL
Intervention: 100 mcg buccal misoprostol
Number of subjects: 153
Study 24405797 — intervention group
Group type: EXPERIMENTAL
Intervention: 200 mcg buccal misoprostol
Number of subjects: 153
Study 22880629 — intervention group
Group type: EXPERIMENTAL
Intervention: Brainstem auditory evoked response (BAER) in NICU term neonates
Number of subjects: 55
Study 22880629 — intervention group
Group type: COMPARATOR
Intervention: Normal term controls
Number of subjects: 55
Study 20389255 — intervention group
Group type: EXPERIMENTAL
Intervention: Paliperidone palmitate 100 mg eq.
Number of subjects: 388
Study 20389255 — intervention group
Group type: EXPERIMENTAL
Intervention: Paliperidone palmitate 50 mg eq.
Number of subjects: 388
Study 20389255 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 388
Study 18992700 — intervention group
Group type: EXPERIMENTAL
Intervention: Levodopa medication withdrawal (experimental group)
Number of subjects: 11
Study 18992700 — intervention group
Group type: COMPARATOR
Intervention: Continued levodopa medication (control group)
Number of subjects: 11
Study 15877999 — intervention group
Group type: EXPERIMENTAL
Intervention: Nifedipine (20 mg/day for 4 months)
Number of subjects: 17
Study 12373663 — intervention group
Group type: EXPERIMENTAL
Intervention: Levetiracetam (1,000 to 4,000 mg)
Number of subjects: 0
Study 12373663 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 11072394 — intervention group
Group type: EXPERIMENTAL
Intervention: Smoking abstinence group (n = 16)
Number of subjects: 21
Study 11072394 — intervention group
Group type: COMPARATOR
Intervention: Continued smoking group (n = 5)
Number of subjects: 21
Study 11072394 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 21
Study 8833936 — intervention group
Group type: EXPERIMENTAL
Intervention: Chronic active hepatitis
Number of subjects: 43
Study 8833936 — intervention group
Group type: EXPERIMENTAL
Intervention: Decompensated liver cirrhosis
Number of subjects: 43
Study 8833936 — intervention group
Group type: EXPERIMENTAL
Intervention: Liver cirrhosis complicated by hepatocellular carcinoma
Number of subjects: 43
Study 8833936 — intervention group
Group type: COMPARATOR
Intervention: Compensated liver cirrhosis
Number of subjects: 43
Study 2205544 — intervention group
Group type: EXPERIMENTAL
Intervention: Ophthalmic rod (OR) with tropicamide
Number of subjects: 0
Study 2205544 — intervention group
Group type: EXPERIMENTAL
Intervention: Ophthalmic rod (OR) with oxybuprocaine HCl
Number of subjects: 0